China Approves Patent for Covid-19 Vaccine


Key Topics in this News Article:

News Snapshot:

The Chinese State Intellectual Property Office (SIPO) approved the first patent for a COVID-19 vaccine candidate – still in the third phase of testing – which could “be mass-produced in a short period of time,” the local press reported today. This vaccine, developed by the Military Scientific Institute and the Chinese biopharmaceutical company CanSino Biologics, began to be used in late June in the Chinese Army after a team led by researcher Chen Wei discovered a highly efficient neutralizing monoclonal antibody. Follow the latest hour on the coronavirus crisis The results of the second phase of the clinical trials of...